FTINX | HBLCX | FTINX / HBLCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 18 years | - |
Gain YTD | 6.366 | 7.151 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | 500 | 2000 | 25% |
Net Assets | 1.99B | 12.4B | 16% |
Annual Yield % from dividends | 2.72 | 2.65 | 103% |
Returns for 1 year | 11.84 | 14.37 | 82% |
Returns for 3 years | -0.38 | -3.42 | 11% |
Returns for 5 years | 16.80 | 11.08 | 152% |
Returns for 10 years | 31.08 | 27.88 | 111% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMIX | 7.99 | -0.03 | -0.37% |
MFS Emerging Markets Equity Research I | |||
PSPIX | 29.09 | -0.27 | -0.92% |
Principal SmallCap S&P 600 Index R6 | |||
JSEQX | 61.33 | -0.59 | -0.95% |
JPMorgan Small Cap Equity R4 | |||
BOPCX | 19.29 | -0.33 | -1.68% |
Sterling Capital Special Opps C | |||
RAGHX | 28.12 | -0.66 | -2.29% |
Virtus KAR Health Sciences A |